Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zepp Health (ZEPP) Gains from Sales and Divestitures (2016 - 2023)

Zepp Health has reported Gains from Sales and Divestitures over the past 8 years, most recently at $224537.0 for Q4 2023.

  • Quarterly results put Gains from Sales and Divestitures at $224537.0 for Q4 2023, up 25.9% from a year ago — trailing twelve months through Dec 2023 was $224537.0 (up 25.9% YoY), and the annual figure for FY2023 was $224537.0, up 18.86%.
  • Gains from Sales and Divestitures for Q4 2023 was $224537.0 at Zepp Health, up from $178343.3 in the prior quarter.
  • Over the last five years, Gains from Sales and Divestitures for ZEPP hit a ceiling of $224537.0 in Q4 2023 and a floor of $73056.1 in Q4 2019.
  • Median Gains from Sales and Divestitures over the past 5 years was $148926.0 (2020), compared with a mean of $141166.1.
  • Biggest five-year swings in Gains from Sales and Divestitures: crashed 56.1% in 2019 and later surged 120.26% in 2022.
  • Zepp Health's Gains from Sales and Divestitures stood at $73056.1 in 2019, then skyrocketed by 103.85% to $148926.0 in 2020, then tumbled by 45.63% to $80968.1 in 2021, then surged by 120.26% to $178343.3 in 2022, then grew by 25.9% to $224537.0 in 2023.
  • The last three reported values for Gains from Sales and Divestitures were $224537.0 (Q4 2023), $178343.3 (Q4 2022), and $80968.1 (Q4 2021) per Business Quant data.